Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$387K Sell
2,634
-26,686
-91% -$4.34M 0.26% 117
2025
Q4
$533K Buy
29,320
+26,015
+787% +$6.19M 0.37% 80
2025
Q3
$930K Buy
3,305
+352
+12% +$89.6K 0.74% 45
2025
Q2
$646K Buy
2,953
+141
+5% +$22.8K 0.52% 63
2025
Q1
$393K Buy
+2,812
New +$458K 0.31% 104
2024
Q4
Sell
-2,442
Closed -$407K 164
2024
Q3
$407K Sell
2,442
-7
-0.3% -$1.01K 0.41% 76
2024
Q2
$341K Buy
2,449
+15
+0.6% +$1.86K 0.36% 83
2024
Q1
$306K Buy
2,434
+12
+0.5% +$1.37K 0.33% 86
2023
Q4
$255K Buy
+2,422
New +$264K 0.32% 91

Other funds holding ORCL

FSA Advisors's ORCL Position: Q1 2026 in Review

FSA Advisors reduced its Oracle (ORCL) stake by 91% in Q1 2026, selling an estimated $4.34M and leaving 2,634 shares worth $387K. The position accounts for 0.26% of the portfolio, ranked #117.

FSA Advisors first reported a position in ORCL in Q4 2023 and has held it in 9 quarters since. The position peaked at $930K in Q3 2025. 3,471 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • FSA Advisors held 2,634 shares of Oracle worth $387K as of Q1 2026.
  • FSA Advisors sold 26,686 Oracle shares in Q1 2026, an estimated $4.34M.
  • Oracle made up 0.26% of FSA Advisors's portfolio in Q1 2026, its #117 holding.
  • FSA Advisors first reported a position in Oracle in Q4 2023 and has held it in 9 quarters since.
  • FSA Advisors's Oracle position peaked at $930K in Q3 2025.
  • 3,471 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on FSA Advisors's 13F filing for Q1 2026, filed 6 May 2026.